Abstract

The latest literature report specifies multifactoral etiology of skin cancer in population of patients after organs transplats. Carcirogenic viruses are one of etiopathogenesis components. Viruses of a vital meaning for skin oncogenesis are called Human papillomavirus – HPV, Human herpesvirus 8 – HHV8 i Merkel cell polyomavirus – MCV. Report on connections exisisting between viruses HPV and skin cancers in the population of patients after organs transplants confirms clinical connection between viruses papillas and cancers centres occuring in similar locations and more frequent appearance of attributes characteristic for HPV infection within the limits of changes in the type of Squamous cell carcinoma (SCC). What’s more, coexisting of viruses papillas and SCC is more often noticed in the population of organ recipients than in the population of healthy people. It is not confirmed yet that any specific correlation between subtypes of HPV and greater frequency of morbidity in skin cancers really exist. However, in the population of organ recipients infections of different types of HPV are found within the limits of cancers centres in the case of SCC (63%) as well as in basal cell carcinoma-BCC (55%). DNA of HPV was also fund in healthy parts of organ recipients skin (92-94%).HHV8 is also an oncogenic viruse that influences the development of lymphoma. Infection of that virus may cause ocuuring of Kaposi’s sarkoma, which is one of the most frequent types of cancer appearing in population of patients treating by long – term immunosuppression in particular geographical zones. MCV, which belongs to the group called Polyomaviriade, owes a particular meaning in etiopathogenesis of Merkel cell carcinoma – MCC. It is a rare cancer derived from neuroendocrine cells of the basic layers of epidermie. For over 30 years it was supposed that correlation between viruses and skin cancers in population of organ recipient exist. Knowledge of the total viruses influence on skin cancers allows to widen the spectrum of anti – cancers prevention in the future.

References

• 1. Ahmed A.M., Madkan V., Tyring S.K.: Human papillomavirusesand genital disease. Dermatol. Clin., 2006; 24: 157-165
  Google Scholar
• 2. Akgul B., Cooke J.C., Storey A.: HPV-associated skin disease. J.Pathol., 2006; 208: 165-175
  Google Scholar
• 3. Bernard H.U., Calleja-Macias I.E., Dunn S.T.: Genome variationof human papillomavirus types: phylogenetic and medical implications.Int. J. Cancer, 2006; 118: 1071-1076
  Google Scholar
• 4. Bienias J., Krzemien S., Mazurek U.: Charakterystyka wirusa Epsteina-Barr – aspekty epidemiologiczne, biomolekularne i transplantologiczne.Postepy Mikrobiol., 2007; 46: 153-165
  Google Scholar
• 5. Blackbourn D.J., Lennette E., Klencke B., Moses A., Chandran B.,Weinstein M., Glogau R.G., Witte M.H., Way D.L., Kutzkey T., HerndierB., Levy J.A.: The restricted cellular host range of human herpesvirus 8 AIDS, 2000; 14: 1123-1133
  Google Scholar
• 6. Boxman I.L., Berkhout R.J., Mulder L.H., Wolkers M.C, BavinckJ.N.B., Vermeer B.J., ter Schegget J.: Detection of human papillomavirusDNA in plucked hairs from renal transplant recipients andhealthy volunteers. J. Invest. Dermatol., 1997; 108: 712-715
  Google Scholar
• 7. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., KnowlesD.M., Moore P.S.: Identification of herpesvirus-like DNA sequencesin AIDS-associated sarcoma. Science,1994; 266: 1865-1869
  Google Scholar
• 8. Crawford D.H.: Biology and disease associations of Epstein-Barrvirus. Philos. Trans. R. Soc. Lond. B Biol. Sci., 2001; 356: 461-473
  Google Scholar
• 9. De Jong-Tieben L.M., Berkhout R.J., Smits H.L., Bouwes BavinckJ.N., Vermeer B.J., van der Woude F.J., ter Schegget J.: High frequencyof detection of epidermodysplasia verruciformis– associated humanpapillomavirus DNA in biopsies from malignant and premalignantskin lesions from renal transplant recipients. J. Invest. Dermatol.,1995; 105: 367-371
  Google Scholar
• 10. de Jong-Tieben L.M., Berkhout R.J., ter Schegget J., Vermeer B.J.,de Fijter J.W., Bruijn J.A., Westendorp R.G., Bouwes Bavinck.J.N.: Theprevalence of human papillomavirus DNA in benign keratotic skin lesionsof renal transplant recipients with and without a history of skincancer is equally high: a clinical study to assess risk factors for keratoticskin lesions and skin cancer. Transplantation, 2000; 69: 44-49
  Google Scholar
• 11. De Villiers E.M.: Papillomavirus and HPV typing. Clin. Dermatol.,1997; 15: 199-206
  Google Scholar
• 12. De Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur HausenH.: Classification of papillomaviruses. Virology, 2004; 324: 17-27
  Google Scholar
• 13. Doorbar J.: The papillomavirus life cycle. J. Clin. Virol., 2005;32: 7-15
  Google Scholar
• 14. Feng H., Shuda M., Chang Y., Moore P.S.: Clonal integration ofa polyomavirus in human Merkel cell carcinoma. Science, 2008;319: 1096-1100
  Google Scholar
• 15. Forslund O., Antonsson A., Nordin P., Stenquist B., HannsonB.G.: A broad range of human papillomavirus types detected witha general PCR method suitable for analysis of cutaneous tumors andnormal skin. J. Gen. Virol., 1999; 80: 2437-2443
  Google Scholar
• 16. Gardner S.D., Field A.M., Coleman D.V., Hulme B.: New humanpapovavirus (B.K) isolated from urine after renal transplantation.Lancet, 1971; 1: 1253-1257
  Google Scholar
• 17. Garner-Hamrick P.A., Fostel J.M., Chien W.M., Banerjee N.S.,Chow L.T., Broker T.R., Fisher C.: Global effects of human papillomavirustype 18 E6/E7 in an organotypic keratinocyte culture system.J. Virol., 2004; 78: 9041-9050
  Google Scholar
• 18. Goh S., Lindau C., Tiveljung-Lindell A., Allander T.: Merkel cellpolyomavirus in respiratory tract secretions. Emerg. Infect. Dis.,2009; 15: 489-491
  Google Scholar
• 19. Grundhoff A., Ganem D.: Inefficient establishment of KSHVlatency suggests an additional role for continued lytic replicationin Kaposi sarcoma pathogenesis. J. Clin. Invest., 2004; 113: 124-136
  Google Scholar
• 20. Hartevelt M.M., Bavinck J.N., Kootte A.M., Vermeer B.J., VandenbrouckeJ.P.: Incidence of skin cancer after renal transplantation inthe Netherlands. Transplantation, 1990; 49: 506-509
  Google Scholar
• 21. Hong Y.K., Foreman K., Shin J.W., Hirakawa S., Curry C.L., SageD.R., Libermann T., Dezube B.J., Fingeroth J.D., Detmar M.: Lymphaticreprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus. Nat. Genet., 2004; 36: 683-685
  Google Scholar
• 22. Jackson S., Harwood C., Thomas M., Banks L., Storey A.: Role ofBak in UV-induced apoptosis in skin cancer and abrogation by HPVE6 proteins. Genes Dev., 2000; 14: 3065-3073
  Google Scholar
• 23. Karagas M.R., Nelson H.H., Sehr P., Waterboer T., Stukel T.A., AndrewA., Green A.C., Bavinck J.N., Perry A., Spencer S., Rees J.R., MottL.A., Pawlita M.: Human papillomavirus infection and incidence ofsquamous cell and basal cell carcinomas of the skin. J. Natl. CancerInst., 2006; 98: 389-395
  Google Scholar
• 24. Karst J., Konopka L.: Poprzeszczepowa choroba limfoproliferacyjna.Onkol. Pol., 2005; 8: 209-216
  Google Scholar
• 25. Kassem A., Schopflin A., Diaz C., Weyers W., Stickeler E., WernerM., Zur Hausen A.: Frequent detection of Merkel cell polyomavirusin human Merkel cell carcinomas and identification of a unique deletionin the VP1 gene. Cancer Res., 2008; 68: 5009-5013
  Google Scholar
• 26. Majewski S., Jablonska S.: Do epidermodysplasia verruciformishuman papillomaviruses contribute to malignant and benign epidermalproliferations? Arch. Dermatol., 2002; 138: 649-654
  Google Scholar
• 27. Majewski S., Jablonska S.: Epidrmodysplasia verruciformis asa model of human papillomavirus-induced genetic cancer of theskin. Arch. Dermatol., 1995; 131: 1312-1318
  Google Scholar
• 28. Majewski S., Jablonska S., Orth G.: Epidermodysplasia verruciformis.Immunological and nonimmunological surveillance mechanisms:role in tumor progression. Clin. Dermatol., 1997;15: 321-334
  Google Scholar
• 29. Matsushima A.Y., Strauchen J.A., Lee G., Scigliano E., Hale E.E.,Weisse M.T., Burstein D., Kamel O., Moore P.S., Chang Y.: Posttransplantationplasmacytic proliferations related to Kaposi’s sarcoma–associated herpesvirus. Am. J. Surg. Pathol., 1999; 23: 1393-1400
  Google Scholar
• 30. Munoz N., Castellsague X., de Gonzalez A.B.: HPV in the etiologyof human cancer. Vaccine, 2006; 24: 1-10
  Google Scholar
• 31. Nevins J.R.: E2F: a link between the Rb tumor suppressor proteinand viral oncoproteins. Science, 1992; 258: 424-429
  Google Scholar
• 32. Orth G., Jablonska S., Favre M., Croissant O., Jarzabek-ChorzelskaM.J., Rzesa G.: Characterization of two types of human papillomavirusesin lesions of epidermodysplasia verruciformis. Proc. Natl.Acad. Sci. USA, 1978; 75: 1537-1541
  Google Scholar
• 33. Rudlinger R., Smith I.W., Bunney M.H., Hunter J.A.: Human papillomavirusinfections in a group of renal transplant recipients. Br.J. Dermatol., 1986; 115: 681-692
  Google Scholar
• 34. Schlecht N.F., Kulaga S., Robitaille J., Ferreira S., Santos M., MiyamuraR.A., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L.,Franco E.L.: Persistent human papillomavirus infection as a predictorof cervical intraepithelial neoplasia. JAMA, 2001; 286: 3106-3114
  Google Scholar
• 35. Schulz T.F.: The pleiotropic effects of Kaposi’s sarcoma herpesvirus.J. Pathol., 2006; 208: 187-198
  Google Scholar
• 36. Shuda M., Feng H., Kwun H.J. Rosen S.T., Gjoerup O., Moore P.S.,Chang Y.: T antigen mutations are a human tumor –specific signaturefor Merkel cell polyomavirus. Proc. Natl. Acad. Sci. USA, 2008;105: 16272-16277
  Google Scholar
• 37. Ulrich C., Kanitakis J., Stockfleth E., Euvrard S.: Skin cancerin organ transplant recipeints – where do we stand today? Am. J.Transplant., 2008; 8: 2192-2198
  Google Scholar
• 38. Viscidi R.P., Shah K.V.: Cancer. A skin cancer virus? Science,2008; 319: 1049-1050
  Google Scholar
• 39. Weissenborn S.J., Nindl I., Purdie K., Harwood C., Proby C., BreuerJ., Majewski S., Pfister H., Wieland U.: Human papillomawirus DNAloads in actinic keratoses exceed those in non-melanoma skin cancers.J. Invest. Dermatol., 2005; 125: 93-97
  Google Scholar
• 40. Zmonarski S.C., Boratynska M., Puziewicz-Zmonarska A., KazimierczakK., Klinger M.: Kaposi’s sarcoma in renal transplant recipients.Ann. Transplant., 2005; 10: 59-65
  Google Scholar
• 41. Zur Hausen H.: Condylomata acuminate and human genitalcancer. Cancer Res., 1976; 36: 794
  Google Scholar
• 42. Zur Hausen H.: Papillomaviruses causing cancer: evasion fromhost-cell control in early events in carcinogenesis. J. Natl. CancerInst., 2000; 92: 690-698
  Google Scholar

Full text